Quitting before surgery: what do complication studies actually show?

01

A successful quit and an uncomplicated operation are not the same endpoint

A wholly fictional example: two people stop smoking before different operations. One develops a wound problem and the other does not. That contrast cannot tell us whether stopping caused the problem or whether a particular number of smoke-free days prevented it. Procedure, underlying illness and care differ; a beneficial intervention does not remove every other cause of complications.

Trials compare an offered cessation programme with a control condition. They do not simply randomize people to successful quitting versus continued smoking. More participants abstaining at a follow-up is one result; fewer respiratory, wound or other postoperative events is another. One cannot stand in for the other.

[1][2][3]

02

The well-known four-to-eight-week finding tested a programme

The 2014 Cochrane review included 13 trials. Two small intensive-programme trials, involving 210 participants, began four to eight weeks before surgery and combined repeated counselling with offered nicotine replacement. They found fewer complications than their controls. Brief programmes did not show a clear complication reduction in the pooled comparison.

This was not a head-to-head trial assigning otherwise identical patients to different quit dates. Timing, support intensity and programme components changed together. It cannot identify an optimal date for your procedure or isolate one component's effect. A January 2025 review, searching to December 2023, still found limited intensive-programme evidence and substantial differences in studies and measurements.

[1][2]

03

Newer reviews do not turn all complications into one outcome

The January 2025 review pooled 14 randomized trials for abstinence, but only seven reported complications. Its overall complication estimate did not clearly distinguish programme and usual-care groups; that is uncertainty, not proof of no benefit. The two intensive trials remained a favourable but small subgroup.

A September 2025 review used different eligibility rules and an English-language search through July 2024. It rated its broadly pooled complication finding as moderate-certainty, while the wound finding was low-certainty and compatible with benefit or no clear difference. Its ‘any complication’, wound and combined estimates were not interchangeable. Different surgical populations, definitions, timing and missing follow-up prevent a single pooled percentage from becoming your personal risk reduction. These reviews do not establish a safe countdown.

[2][3]

04

Take the timing question to the team, not an online calculator

Tell the surgeon and anaesthesia professional about smoking and any cessation medicines or nicotine products so they can plan care. Useful questions are whether cessation support can be arranged now, how it fits the scheduled procedure and whom to contact if the situation changes. Do not independently postpone an operation or start, stop or alter medication because of a study's interval. A short time remaining is a reason to ask the team, not a reason to conceal smoking or assume quitting is pointless.

In England, NHS local stop-smoking services provide separate help; confirm access, and use local services elsewhere. They do not decide surgical fitness or replace the hospital's instructions. This page collects no operation date, symptoms or smoking history and gives no anaesthesia, medication or surgical scheduling plan.

[1][2][3][4][5]

05

What to keep in mind

• Programme trials measure both abstinence and complications; they are different endpoints.
• Four to eight weeks describes particular programmes, not individual surgical clearance.
• Discuss support and timing with the surgical team; do not change the operation or medicines yourself.